Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 5
2023 6
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Immunglobulin-M-Schleimhautpemphigoid.
Yilmaz K, Hammers CM, Boch K, Zillikens D, Shimanovich I, Schmidt E. Yilmaz K, et al. J Dtsch Dermatol Ges. 2023 Mar;21(3):285-287. doi: 10.1111/ddg.14973_g. J Dtsch Dermatol Ges. 2023. PMID: 36929547 No abstract available.
[Rare variants of pemphigoid diseases].
Yilmaz K, Kiehne C, Holtsche MM, Schmidt E. Yilmaz K, et al. Dermatologie (Heidelb). 2022 Dec;74(12):937-947. doi: 10.1007/s00105-023-05242-2. Epub 2023 Oct 17. Dermatologie (Heidelb). 2022. PMID: 37847383 Review. German.
Unusual Mucosal Spots in Adulthood.
Yilmaz K, Anemüller W. Yilmaz K, et al. Dtsch Arztebl Int. 2022 Feb 16;119(50):875. doi: 10.3238/arztebl.m2022.0290. Dtsch Arztebl Int. 2022. PMID: 36876413 Free article. No abstract available.
Immunoglobulin M mucous membrane pemphigoid.
Yilmaz K, Hammers CM, Boch K, Zillikens D, Shimanovich I, Schmidt E. Yilmaz K, et al. J Dtsch Dermatol Ges. 2023 Mar;21(3):285-287. doi: 10.1111/ddg.14973. Epub 2023 Feb 11. J Dtsch Dermatol Ges. 2023. PMID: 36772920 No abstract available.
Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients.
Emtenani S, Holtsche MM, Stahlkopf R, Seiler DL, Burn T, Liu H, Parker M, Yilmaz K, Dikmen HO, Lang MH, Sadik CD, Karsten CM, van Beek N, Ludwig RJ, Köhl J, Schmidt E. Emtenani S, et al. Among authors: yilmaz k. Front Immunol. 2022 Nov 18;13:942493. doi: 10.3389/fimmu.2022.942493. eCollection 2022. Front Immunol. 2022. PMID: 36466856 Free PMC article.
The gut microbiome in bullous pemphigoid: implications of the gut-skin axis for disease susceptibility.
Liu X, van Beek N, Cepic A, Andreani NA, Chung CJ, Hermes BM, Yilmaz K, Benoit S, Drenovska K, Gerdes S, Gläser R, Goebeler M, Günther C, von Georg A, Hammers CM, Holtsche MM, Hübner F, Kiritsi D, Schauer F, Linnenmann B, Huilaja L, Tasanen-Määttä K, Vassileva S, Zillikens D, Sadik CD, Schmidt E, Ibrahim S, Baines JF. Liu X, et al. Among authors: yilmaz k. Front Immunol. 2023 Nov 10;14:1212551. doi: 10.3389/fimmu.2023.1212551. eCollection 2023. Front Immunol. 2023. PMID: 38022583 Free PMC article.
Clinical and Serological Characterization of Orf-Induced Immunobullous Disease.
Yilmaz K, Goletz S, Pas HH, van den Bos RR, Blauvelt A, White WL, Bouaziz JD, Zuelgaray E, Daneshpazhooh M, Yancey KB, Goebeler M, Schmidt E. Yilmaz K, et al. JAMA Dermatol. 2022 Jun 1;158(6):670-674. doi: 10.1001/jamadermatol.2022.0290. JAMA Dermatol. 2022. PMID: 35353128 Free PMC article.
Anti-BP230 Only Bullous Pemphigoid Constitutes a Distinct Disease Subgroup with Characteristic Serological and Clinical Features.
Ramcke T, Bolduan V, Vicari E, Yilmaz K, Bertlich I, Goletz S, Mindorf S, Hoffmann J, Schmidt E, Enk A, Hadaschik E. Ramcke T, et al. Among authors: yilmaz k. J Invest Dermatol. 2022 Nov;142(11):3110-3113.e8. doi: 10.1016/j.jid.2022.05.1084. Epub 2022 Jun 6. J Invest Dermatol. 2022. PMID: 35671826 Free article. No abstract available.
15 results